NCT06943612 Colorectal Resections in Patients With Retroperitoneal Sarcoma
| NCT ID | NCT06943612 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Heidelberg University |
| Condition | Sarcoma, Soft Tissue |
| Study Type | OBSERVATIONAL |
| Enrollment | 120 participants |
| Start Date | 2025-01-27 |
| Primary Completion | 2026-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 120 participants in total. It began in 2025-01-27 with a primary completion date of 2026-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
COLOSARC-Q is a multicenter study with the objective of providing an up-to-date assessment of colorectal resections and reconstruction techniques in the context of multivisceral resections for retroperitoneal sarcomas, as well as colorectal surgery-associated complications and their impact on patients' quality of life. In multivisceral resections involving the colon and rectum, the primary aim is to achieve complete resection and preserve organ function. However, multivisceral resections have a high risk of perioperative morbidity including anastomotic leakage. The proposed project aims to determine the number of primary anastomoses, their insufficiency rates, and the fraction of patients with primary and secondary stomas. In addition, the patients' quality of life after multivisceral sarcoma resection is to be recorded using standardized surveys. The analysis has the potential to facilitate intraoperative decision-making for colorectal resections in the context of multivisceral resections.
Eligibility Criteria
Inclusion Criteria: * Histological confirmation with evidence of a retroperitoneal sarcoma * Tumor resection with colorectal resection * Surgery in a DKG-certified sarcoma center or hospital that meets certification-equivalent criteria * Age 18 years or older * Written consent Exclusion Criteria: * Absence of consent
Contact & Investigator
Jens Jakob, Prof.
PRINCIPAL INVESTIGATOR
Sarcoma Unit, Department of Surgery, University Medical Center Mannheim, Theodor-Kutzer-Ufer 1-3, 68167 Mannheim, Germany
Frequently Asked Questions
Who can join the NCT06943612 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Sarcoma, Soft Tissue. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06943612 currently recruiting?
Yes, NCT06943612 is actively recruiting participants. Contact the research team at Jens.Jakob@umm.de for enrollment information.
Where is the NCT06943612 trial being conducted?
This trial is being conducted at Mannheim, Germany, Berlin, Germany, Dresden, Germany, Erlangen, Germany and 9 additional locations.
Who is sponsoring the NCT06943612 clinical trial?
NCT06943612 is sponsored by Heidelberg University. The principal investigator is Jens Jakob, Prof. at Sarcoma Unit, Department of Surgery, University Medical Center Mannheim, Theodor-Kutzer-Ufer 1-3, 68167 Mannheim, Germany. The trial plans to enroll 120 participants.